TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
COAG

Hemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

31.60$ +2.4% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement COAG
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – –
– – – –
– – – –
– -8.7% +51.2% +4.5%
– +29.4% +30.4% +38.4%
– -3.0% +47.1% +10.4%
– – – –
– – – –
– – – +708.3%
– – – –
– – – –

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?